Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
You can purchase shares of Lyra Therapeutics (NASDAQ:LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Gelteq (NASDAQ:GELS), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).
Lyra Therapeutics has a consensus price target of $8.38.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $0.186 last updated November 15, 2024 at 8:06 AM EST.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.